Forward Citations = 0

Loading Chart...

21 inventors (with patents filed for the assignee):

Song Hee Lee (2 out of 3 patents)

Ji Youn Park (2 out of 2 patents)

Je Ho Ryu (2 out of 2 patents)

4. Ho Hyun Lee (2 out of 2 patents)

5. Jung Min Ahn (2 out of 2 patents)

6. Sung Yun Cho (1 out of 14 patents)

7. Jong Yeon Hwang (1 out of 10 patents)

8. Jae Du Ha (1 out of 10 patents)

9. Pil Ho Kim (1 out of 5 patents)

10. Chi Hoon Park (1 out of 9 patents)

11. Hyun Jin Kim (1 out of 19 patents)

12. Ji Young Kim (1 out of 4 patents)

13. Ye Seul Lim (1 out of 1 patent)

14. Hee Jung Moon (1 out of 1 patent)

15. Beom Seon Suh (1 out of 1 patent)

2 patents: Sort by Forward Citations

1. 12161722 - Bifunctional heterocyclic compound having BTK degradation function via ubiquitin proteasome pathway, and use thereof (2024-12-10),

2. 12122763 - Substituted piperidines for androgen receptor degradation (2024-10-22),

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

2 Patents

#1,299 in Seoul

#3,791 in South Korea

Seoul, South Korea

Ubix Therapeutics, Inc.

Forward Citations = 0

21 inventors:

Song Hee Lee (2 out of 3 patents)

Ji Youn Park (2 out of 2 patents)

Je Ho Ryu (2 out of 2 patents)

4. Ho Hyun Lee (2 out of 2 patents)

5. Jung Min Ahn (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ubix Therapeutics, Inc.. Retrieved from https://idiyas.com/company/ubix-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]